Epigenetic Marks in Polycystic Ovary Syndrome

Author(s): Alicia Beatriz Motta*

Journal Name: Current Medicinal Chemistry

Volume 27 , Issue 39 , 2020

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Polycystic Ovary Syndrome (PCOS) is a common endocrine and metabolic disorder that affects women in their reproductive age. Recent studies have shown that genes have an important role in the etiology of PCOS. However, the precise way in which these genes are transcriptionally and post-transcriptionally regulated is poorly understood.

The aim of the present review is to provide updated information on miRNAs and DNA methylation as epigenetic marks of PCOS.

The data presented here allow concluding that both microRNAs and DNA methylation can be considered as possible useful biomarkers when choosing the treatment for a specific PCOS phenotype and thus represent two important tools for the diagnosis and treatment of PCOS patients.

Keywords: Polycystic ovary syndrome, epigenetic marks, miRNAs, DNA methylation, PCOS phenotypes, PCOS treatment.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 24 November, 2020
Page: [6727 - 6743]
Pages: 17
DOI: 10.2174/0929867326666191003154548
Price: $65

Article Metrics

PDF: 34